Drug Type Small molecule drug |
Synonyms Claritin/Singulair, Loratadine/montelukast, Montelukast/loratadine |
Target |
Action antagonists |
Mechanism CysLT1 antagonists(Cysteinyl leukotriene receptor 1 antagonists), H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC22H23ClN2O2 |
InChIKeyJCCNYMKQOSZNPW-UHFFFAOYSA-N |
CAS Registry79794-75-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rhinitis, Allergic, Seasonal | NDA/BLA | United States | - | |
Rhinitis, Allergic, Seasonal | NDA/BLA | - | - | |
Rhinitis, Allergic, Perennial | Phase 3 | - | 04 Jul 2012 |
Phase 3 | 69 | (Montelukast 10 mg/Loratadine 10 mg) | oinwbmzgoi = ovlhezhdmt pmshemwybg (dllzsvihfs, oekejdwpcv - dsyzyztiph) View more | - | 14 Nov 2014 | ||
Placebo (Placebo) | oinwbmzgoi = zphlbdsnfv pmshemwybg (dllzsvihfs, hcuwdnayvg - fqtpitgxsp) View more | ||||||
Phase 3 | 907 | (Placebo) | edzrblxxas(slpgajakdp) = syhfstsukm ivloskoxcl (basgfgvxpl, pnnpbjkzzb - ebfpeciyaq) View more | - | 16 Jun 2010 | ||
(Montelukast) | edzrblxxas(slpgajakdp) = asbaesgije ivloskoxcl (basgfgvxpl, jwuvkyajec - yswubzruyp) View more |